Stockscreener 앱 받기
2.00
8.11%
0.15
시장 영업 전:
2.09
0.09
+4.50%
Immunoprecise Antibodies Ltd 주식(IPA)의 최신 뉴스
Angi (ANGI) Q2 Revenue Beats by 6% - AOL.com
Inmune Bio Inc. shares fall 1.09% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt. - AInvest
Sensei (SNSE) Q2 Loss Narrows 31% - AOL.com
Aurinia (AUPH) Q2 Revenue Jumps 22% - AOL.com
ImmunoPrecise Antibodies Divests Netherlands Facilities to AVS Bio - citybiz
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2025 Earnings Call Transcript - MSN
Beta Bionics (BBNX) Q2 Revenue Soars 54% - AOL.com
ImmunoPrecise Antibodies divests Netherlands facilities to AVS Bio - MSN
AVS Bio, an Arlington Capital Partners Portfolio Co. Acquires ImmunoPrecise Antibodies Europe - citybiz
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation - Silicon Canals
ImmunoPrecise Antibodies Divests Dutch Subsidiary to Focus on AI Innovation - TipRanks
ImmunoPrecise Antibodies sells Netherlands subsidiary to AVS Bio for $12m - Investing.com Australia
AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd. - Business Wire
TR | OpenAI4o Initiates ImmunoPrecise Antibodies(IPA.US) With Hold Rating, Announces Target Price $2 - 富途牛牛
Day One (DAWN) Q2 Revenue Jumps 313% - AOL.com
Prothena Q2 Revenue Drops 97% - AOL.com
Agilon Health (AGL) Q2 Revenue Falls 6% - AOL.com
ImmunoPrecise (IPA) Q4 2025 Earnings Transcript - Mitrade
ITRM Reports Results - AOL.com
Idexx (IDXX) Q2 Revenue Jumps 11% - AOL.com
What institutional investors are buying ImmunoPrecise Antibodies Ltd. stockUnstoppable trading performance - Jammu Links News
What catalysts could drive ImmunoPrecise Antibodies Ltd. stock higher in 2025High-yield market plays - Jammu Links News
ImmunoPrecise Antibodies Ltd. Stock Analysis and ForecastSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for ImmunoPrecise Antibodies Ltd. in the next 12 monthsDynamic growth stocks - Jammu Links News
What drives ImmunoPrecise Antibodies Ltd. stock priceTremendous wealth creation - Jammu Links News
What is ImmunoPrecise Antibodies Ltd. company’s growth strategyExtraordinary market timing - Jammu Links News
What makes ImmunoPrecise Antibodies Ltd. stock price move sharplyInvest smarter with advanced market data - Jammu Links News
What are the latest earnings results for ImmunoPrecise Antibodies Ltd.Build a diversified portfolio for maximum returns - Jammu Links News
Why is ImmunoPrecise Antibodies Ltd. stock attracting strong analyst attentionWealth Building Planner With Proven Results - Jammu Links News
ImmunoPrecise Antibodies Announces Details for October 2025 Annual Meeting - TipRanks
Does ImmunoPrecise Antibodies Ltd. stock perform well during market downturnsFinancial News Updates For Consistent Profits - Jammu Links News
What does recent volatility data suggest for ImmunoPrecise Antibodies Ltd.Technical Entry Plan with Risk Minimization - Newser
Is ImmunoPrecise Antibodies Ltd. stock bottoming outFree Accurate Buy Point for Momentum Stocks - Newser
Is ImmunoPrecise Antibodies Ltd. stock ready for a breakoutWeekly Chart-Based Forecast for Traders - Newser
ImmunoPrecise Antibodies Full Year 2025 Earnings: Misses Expectations - sg.finance.yahoo.com
How Efficient Is ImmunoPrecise Antibodies Ltd. at Controlling Operating CostsTechnical Trade Plan with Entry Checklist - Newser
Is ImmunoPrecise Antibodies Ltd. forming a reversal patternFree Swing Setup With Technical Confirmation - Newser
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ... By GuruFocus - Investing.com Canada
ImmunoPrecise Antibodies Ltd (IPA) Q4 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
Detecting support and resistance levels for ImmunoPrecise Antibodies Ltd.Short Term Opportunity Finder with Tools - Newser
ImmunoPrecise Antibodies Ltd. Reports Strategic Focus Amid Financial Challenges - TipRanks
Immunoprecise Antibodies Q4 2025 Earnings Call Transcript: Financial Performance, Strategic Initiatives, and Operational Highlights - AInvest
ImmunoPrecise Antibodies Reports Record Revenue and Growth - TipRanks
ImmunoPrecise Antibodies Q4 2025 Earnings Call Transcript - MarketBeat
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN
What technical models suggest about ImmunoPrecise Antibodies Ltd.’s comebackFree Fundamental Winners With Safe Entry Plan - Newser
Investors ignore increasing losses at ImmunoPrecise Antibodies (NASDAQ:IPA) as stock jumps 15% this past week - simplywall.st
Earnings call transcript: ImmunoPrecise sees record revenue in Q4 2025 By Investing.com - Investing.com Nigeria
Earnings call transcript: ImmunoPrecise sees record revenue in Q4 2025 - Investing.com
ImmunoPrecise Bets Big On BioStrand Growth And AI Focus - Finimize
Why ImmunoPrecise Antibodies Ltd. stock attracts strong analyst attentionMulti-Bagger Potential Stock Forecast Tools Released - metal.it
Immunoprecise Antibodies Ltd reports results for the quarter ended April 30Earnings Summary - TradingView
0.24%
3.39%
자본화:
|
볼륨(24시간):